XML 92 R79.htm IDEA: XBRL DOCUMENT
v3.21.2

Fair Value Considerations - Contingent Value Rights (Details) - Innovus - USD ($) $ in Thousands |  |  | 3 Months Ended |
--- | --- | --- | --- | ---
Mar. 20, 2021 | Mar. 31, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Jun. 30, 2021
Fair Value Considerations |  |  |  |  |
Additional maximum contingent consideration |  |  | $ 16,000 |  |
Maximum shares to be issued to settle CVR shares |  |  | 470,000 |  |
Number of shares issued to contingent value rights share holders | 103,190 | 123,820 |  |  |
Contingent value rights amount | $ 1,000 | $ 2,000 |  |  |
First milestone | $ 30,000 |  | $ 24,000 |  |
Milestone not met during the year |  |  | 1,000 |  |
Gain (loss) from change in fair value of CVR |  |  | 47 | $ (100) |
CVR liability |  |  | $ 1,300 |  | $ 1,400

X
- Definition The first revenue milestone for contingent value rights holders of the business acquisition. + References No definition available. + Details
Name: | aytu_BusinessCombinationContingentValueRightsFirstRevenueMilestone
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The maximum amount of contingent value rights of the business combination. + References No definition available. + Details
Name: | aytu_BusinessCombinationContingentValueRightsMaximumRangeOfOutcomes
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent value rights revenue milestone not met during the year. + References No definition available. + Details
Name: | aytu_BusinessCombinationContingentValueRightsRevenueMilestoneNotMetDuringYear
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The maximum number of shares that would be issued to settle the contingent value rights issued in the business acquisition. + References No definition available. + Details
Name: | aytu_BusinessCombinationMaximumSharesToBeIssuedToSettleCVR
Namespace Prefix: | aytu_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value portion of contingent value rights. + References No definition available. + Details
Name: | aytu_ContingentValueRightsLiabilitiesFairValueDisclosure
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of gain (loss) from change in fair value of CVR. + References No definition available. + Details
Name: | aytu_GainLossFromChangeInFairValueOfCVR
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares of stock issued during the period to the contingent value rights holders. + References No definition available. + Details
Name: | aytu_StockIssuedDuringPeriodSharesContingentValueRights
Namespace Prefix: | aytu_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The value of stock issued during the period for contingent value rights. + References No definition available. + Details
Name: | aytu_StockIssuedDuringPeriodValueContingentValueRights
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |